USC Schaeffer Center co-director testifies at U.S. Senate hearing
Erin Trish testified about pharmacy benefit managers before the Committee on Commerce, Science and Transportation.
A potential solution to the opioid epidemic: Tell doctors their patients fatally overdosed
The USC team’s study showed that an informational letter from the county medical examiner reduced the number of opioid prescriptions clinicians wrote.
Roe v. Wade repeal may exacerbate women’s health inequities even as candidates use it to gain votes, USC experts say
Health experts see abortion as a public health issue — but in politics, it’s a campaign issue and this is a critical election year.
Failures in the generic drug market cost patients millions
Growing evidence suggests that U.S. consumers overpay for generics by as much as 20% while pharmacy benefit managers pad profits, a USC Schaeffer Center white paper finds.
Supreme Court abortion ruling on Roe v. Wade: 5 things that could happen next
A USC expert on medicine access, drug utilization and pharmaceutical policy weighs in on what’s at stake across the country.
Lax regulation of U.S. cannabis market could have unexpected consequences
USC Schaeffer Center Senior Fellow Rosalie Liccardo Pacula warns of potential impact to public health.
Why is insulin so expensive? Middlemen take half the profit
USC Schaeffer study tracks down the insulin pricing and distribution chain.
USC’s Paul Ginsburg elected to the National Academy of Medicine
Ginsburg, a senior fellow at the USC Schaeffer Center and professor of practice at USC Price, was recognized for his role in shaping and influencing health policy.
Deaths tied to opioids rose among less-educated whites during stay-home order
Opioid-related deaths among Blacks, Asians and Latinos dropped during the same period, according to a study from USC and the L.A. County Medical Examiner-Coroner’s Office.
As Health Disparities Grow in America, USC Researchers Look for Answers in the Data
With racial and socioeconomic inequality come inequities in well-being.
From legalizing marijuana to decriminalizing opioids, USC professor does the research to inform change
While Congress considers proposals for federal drug liberalization including legalizing marijuana and decriminalization, Rosalie Liccardo Pacula is working to inform decisions regarding possible regulations through research.
COVID-19 vaccination mandates for employees and students are effective against virus spread
Private sector influence plus a market demand for mandates will likely overcome state laws that have limited vaccine requirements thus far, a USC study finds.
Costco beats Medicare in generic drug savings nearly 50% of the time
Intermediaries are negotiating good drug prices but lack the incentives to pass savings to beneficiaries and taxpayers, a USC study finds.
Why does L.A. have so many COVID-19 cases?
A lack of affordable housing and the resulting crowded apartments play a major role in L.A. County’s nearly 1.2 million confirmed coronavirus cases, USC experts say.
Monthly cost sharing doubles throughout the year for some Medicare insulin users
Despite insulin’s importance to these patients, increases in out-of-pocket spending were associated with reduced drug adherence, USC research finds.
Surprise medical bills increase costs for everyone, not just for the people who get them
Eliminating surprise medical bills offers the potential to lower health insurance premiums across the board, say three USC health economists and policy analysts.
New Alzheimer’s treatments won’t be widely accessible without changes to national health systems
USC research shows how several major countries could prepare their health systems to ensure patients can get Alzheimer’s treatments once they hit the market.
To reduce health disparities, new digital dataset focuses on underrepresented Americans
USC Schaeffer Center researchers are heading up the American Life in Real-time initiative, which will collect data from across all socio-demographic groups in an attempt to lessen systemic inequity.
COVID-19 treatments, not just vaccines, will save lives and generate value
Treatments for COVID-19 would deliver up to $106 billion in gains by the end of 2021, a new analysis from the USC Schaeffer Center finds.
Keck School of Medicine of USC adds health justice to medical student curriculum
The Physician-Citizen-Scholar curriculum will be implemented in fall 2021 with the Class of 2025.
Fast-acting countries cut their coronavirus death rates while U.S. delays cost thousands of lives
Countries with large vulnerable populations especially benefited from moving quickly, USC experts find.
Why the WHO, often under fire, has a tough balance to strike in its efforts to address health emergencies
As the world confronts a pandemic, the World Health Organization finds itself under a storm of criticism. A USC health policy expert asks: To what extent can we say the agency did not provide adequate information?
Who will lead the economic recovery from COVID-19? Start with those who’ve recovered
A visiting scholar at the USC Schaeffer Center envisions a certification system that would allow people who’ve recovered from COVID-19 to begin jump-starting the economy.
Some U.S. coronavirus curves are starting to flatten — find out where
Some states issued stay-at-home measures earlier than others. Has it made a difference? Here’s what USC Schaeffer Center experts say.